Come up with a name for your new list and we'll add to it:
StrideBio raised a round of funding on June 01, 2017. Investors include
Hatteras Venture Partners.
StrideBio is a gene therapy company focused on creating and developing novel adeno-associated viral (AAV) vector technologies. The company is building a proprietary therapeutic pipeline focused on rar…